Sotera Wireless said it has upgraded its ViSi Mobile patient monitoring system to detect atrial fibrillation, ventricular fibrillation and ventricular tachycardia, and to provide asystole analysis.
Often asymptomatic, atrial fibrillation may remain undiagnosed until or even after the development of complications, such as stroke. Post-operative atrial fibrillation is the most common arrhythmia that occurs after both cardiac and noncardiac surgery and is associated with increased morbidity, longer hospital stays and higher hospital costs.
ViSi Mobile was previously FDA-cleared to monitor continuous noninvasive blood pressure (cNIBP), functional oxygen saturation of arterial hemoglobin (SpO2), heart rate, pulse rate, ECG activity, respiration rate and skin temperature in hospital-based facilities.
The upgrade, ViSi Mobile 1.5G, was also cleared to track and alert medical personnel to undesirable patient positions, patient immobility, and patient falls as well as display patient movement and posture (stationary, reclined, lying-down or walking), the company said.
Sotera filed for Chapter 11 bankruptcy protection in September 2016, saying it owed its main creditors roughly $13.1 million. Sotera reported raising about $20.7 million back in April 2014 and acquired sensor developer Reflectance Medical for an undisclosed amount the next year.
At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart. Shultz will take attendees behind the story that everyone is talking about: the rise and fall of Elizabeth Holmes and her diagnostic company, Theranos.
Join Shultz and 1,000+ medical device professionals at the 8th annual DeviceTalks Boston.